Step one for TraceLink, a maker of software that helps track the supply chain of pharmaceuticals, was recruiting hundreds of thousands of companies and organizations to its digital platform.
Now, much like the playbooks of social media companies and other tech... Read more »
The long, sometimes painful wait to complete an MRI may soon be cut down dramatically—and we might have Facebook and its artificial intelligence unit to thank for it.
The social media giant announced Monday that it is working with the radiology... Read more »
In its early years, Uber was a headstrong force knocking down preconceived ideas about transportation and, along with Lyft, sparking the imaginations of countless entrepreneurs who are now building a new industry called “mobility.”
As it closes in on its first... Read more »
Over the past few years, immunotherapy has rapidly begun to change how lung cancer is treated. But it hasn’t been an option for patients with a particularly aggressive form of the disease, small cell lung cancer (SCLC), until today.
The FDA... Read more »
[Updated 8/17/18, 10:21 a.m. See below.] We’ll start the roundup this week with two drug approvals that came late last Friday. Both were landmarks for the companies receiving the nod, Alnylam Pharmaceuticals and Amicus Therapeutics.
We also saw a... Read more »
DoorDash has upped its valuation to $4 billion with a new $250 million financing round, five months after it raised $535 million to gain its “unicorn” status.
The new $250 million funding round was co-led by Coatue Management and DST Global.... Read more »
A new class of pain drugs that might offer an alternative to addictive opioids—if they’re safe enough to use chronically—is inching closer to an FDA review.
Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Teva Pharmaceutical (NYSE: TEVA) said this morning... Read more »
Pfizer has become the latest drug maker to bet that synthetic messenger RNA molecules (mRNA) can be a new source for vaccines.
This morning, the New York pharma company cut a deal with BioNTech, of Germany, to co-develop mRNA vaccines for... Read more »
After a sluggish start to 2018, hiring has accelerated recently at the top software companies in three of America’s largest technology hubs.
That’s according to the latest quarterly Digital Jobs Index compiled by John Barrett, a Boston-area partner with executive... Read more »
Houston—Sometimes, when a startup has matured to a certain point, a founder is not considered to be the best person to lead it during the next stage of growth. At Station Houston, a startup-focused organization founded in 2016, new leadership... Read more »
Austin—Bumble, the dating app maker that has expanded into other areas of social networking, has launched an investment fund focused on startups founded by women.
The Bumble Fund plans to make early stage investments that focus on diverse female founders... Read more »
There’s a new venture fund in town, focused on the hypiest of hyped sectors right now: blockchain systems and cryptocurrencies. It’s a small fund, but what’s interesting about Castle Island Ventures is the pedigree of the Boston firm’s founders and the... Read more »
Ford—one of the automakers competing in China’s huge car market—is now making a bid to provide China’s leading software infrastructure hub dedicated to streamlining transportation by connecting cars and riders with mobility services.
Ford’s recently acquired unit Autonomic, which co-created... Read more »